OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
BORIS/CTCFL promotes a switch from a proliferative towards an invasive phenotype in melanoma cells
Sanne Janssen, Roy Moscona, Mounib Elchebly, et al.
Cell Death Discovery (2020) Vol. 6, Iss. 1
Open Access | Times Cited: 24
Sanne Janssen, Roy Moscona, Mounib Elchebly, et al.
Cell Death Discovery (2020) Vol. 6, Iss. 1
Open Access | Times Cited: 24
Showing 24 citing articles:
The amoeboid state as part of the epithelial-to-mesenchymal transition programme
Vittoria Graziani, Irene Rodríguez‐Hernández, Óscar Maiques, et al.
Trends in Cell Biology (2021) Vol. 32, Iss. 3, pp. 228-242
Open Access | Times Cited: 109
Vittoria Graziani, Irene Rodríguez‐Hernández, Óscar Maiques, et al.
Trends in Cell Biology (2021) Vol. 32, Iss. 3, pp. 228-242
Open Access | Times Cited: 109
Effects of statins on brain tumors: a review
Amir R. Afshari, Hamid Mollazadeh, Neil C. Henney, et al.
Seminars in Cancer Biology (2020) Vol. 73, pp. 116-133
Open Access | Times Cited: 70
Amir R. Afshari, Hamid Mollazadeh, Neil C. Henney, et al.
Seminars in Cancer Biology (2020) Vol. 73, pp. 116-133
Open Access | Times Cited: 70
Understanding Molecular Mechanisms of Phenotype Switching and Crosstalk with TME to Reveal New Vulnerabilities of Melanoma
Ahmad Najem, Laura Soumoy, Malak Sabbah, et al.
Cells (2022) Vol. 11, Iss. 7, pp. 1157-1157
Open Access | Times Cited: 23
Ahmad Najem, Laura Soumoy, Malak Sabbah, et al.
Cells (2022) Vol. 11, Iss. 7, pp. 1157-1157
Open Access | Times Cited: 23
CTCF and Its Multi-Partner Network for Chromatin Regulation
Aylin Del Moral‐Morales, Marisol Salgado-Albarrán, Yesennia Sánchez-Pérez, et al.
Cells (2023) Vol. 12, Iss. 10, pp. 1357-1357
Open Access | Times Cited: 12
Aylin Del Moral‐Morales, Marisol Salgado-Albarrán, Yesennia Sánchez-Pérez, et al.
Cells (2023) Vol. 12, Iss. 10, pp. 1357-1357
Open Access | Times Cited: 12
BORIS/CTCFL epigenetically reprograms clustered CTCF binding sites into alternative transcriptional start sites
Elena M. Pugacheva, Dharmendra Nath Bhatt, Samuel Rivero-Hinojosa, et al.
Genome biology (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 4
Elena M. Pugacheva, Dharmendra Nath Bhatt, Samuel Rivero-Hinojosa, et al.
Genome biology (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 4
Jun/Fos promotes migration and invasion of hepatocellular carcinoma cells by enhancing BORIS promoter activity
Longjun Xian, Yimei Xiong, Lu Qin, et al.
The International Journal of Biochemistry & Cell Biology (2024) Vol. 169, pp. 106540-106540
Closed Access | Times Cited: 3
Longjun Xian, Yimei Xiong, Lu Qin, et al.
The International Journal of Biochemistry & Cell Biology (2024) Vol. 169, pp. 106540-106540
Closed Access | Times Cited: 3
Analytical performance of a standardized kit for mass spectrometry-based measurements of human glycosaminoglycans
Davide Tamburro, Siniša Bratulić, Souad Abou Shameh, et al.
Journal of Chromatography B (2021) Vol. 1177, pp. 122761-122761
Open Access | Times Cited: 15
Davide Tamburro, Siniša Bratulić, Souad Abou Shameh, et al.
Journal of Chromatography B (2021) Vol. 1177, pp. 122761-122761
Open Access | Times Cited: 15
Molecular characterization of renal cell carcinoma tumors from a phase III anti-angiogenic adjuvant therapy trial
Robert J. Motzer, Jean‐François Martini, Xinmeng Jasmine Mu, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 11
Robert J. Motzer, Jean‐François Martini, Xinmeng Jasmine Mu, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 11
An H3K4me3 reader, BAP18 as an adaptor of COMPASS-like core subunits co-activates ERα action and associates with the sensitivity of antiestrogen in breast cancer
Ge Sun, Chunyu Wang, Shengli Wang, et al.
Nucleic Acids Research (2020) Vol. 48, Iss. 19, pp. 10768-10784
Open Access | Times Cited: 15
Ge Sun, Chunyu Wang, Shengli Wang, et al.
Nucleic Acids Research (2020) Vol. 48, Iss. 19, pp. 10768-10784
Open Access | Times Cited: 15
Breast-cancer detection using blood-based infrared molecular fingerprints
Kosmas V. Kepesidis, Maša Božić‐Iven, Marinus Huber, et al.
BMC Cancer (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 14
Kosmas V. Kepesidis, Maša Božić‐Iven, Marinus Huber, et al.
BMC Cancer (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 14
Characterization of molecular subtypes based on chromatin regulators and identification of the role of NPAS2 in lung adenocarcinoma
Yongbiao Huang, Lingyan Xiao, Motuma Yigezu Daba, et al.
Clinical Epigenetics (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Yongbiao Huang, Lingyan Xiao, Motuma Yigezu Daba, et al.
Clinical Epigenetics (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Patient-specific gene networks reveal novel subtypes and predictive biomarkers in lung cancer
Patricio López-Sánchez, Federico Ávila‐Moreno, Enrqiue Hernandez-Lemus, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Patricio López-Sánchez, Federico Ávila‐Moreno, Enrqiue Hernandez-Lemus, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
BORIS/CTCFL expression activates the TGFβ signaling cascade and induces Drp1 mediated mitochondrial fission in neuroblastoma
Venkata Krishna Kanth Makani, Jolly Janette Mendonza, Prajitha Mohandas Edathara, et al.
Free Radical Biology and Medicine (2021) Vol. 176, pp. 62-72
Closed Access | Times Cited: 10
Venkata Krishna Kanth Makani, Jolly Janette Mendonza, Prajitha Mohandas Edathara, et al.
Free Radical Biology and Medicine (2021) Vol. 176, pp. 62-72
Closed Access | Times Cited: 10
CTCFL regulates the PI3K-Akt pathway and it is a target for personalized ovarian cancer therapy
Marisol Salgado-Albarrán, Julian Späth, Rodrigo González‐Barrios, et al.
npj Systems Biology and Applications (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 7
Marisol Salgado-Albarrán, Julian Späth, Rodrigo González‐Barrios, et al.
npj Systems Biology and Applications (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 7
Clinical Utility of Noncoding RNAs as Systemic Biomarkers in Animal Models
Siuli Shaw, Sartaj Khurana, Ayushi Mukherjee, et al.
Handbook of Animal Models and its Uses in Cancer Research (2023), pp. 1107-1123
Closed Access | Times Cited: 2
Siuli Shaw, Sartaj Khurana, Ayushi Mukherjee, et al.
Handbook of Animal Models and its Uses in Cancer Research (2023), pp. 1107-1123
Closed Access | Times Cited: 2
Roy Moscona, Sanne Janssen, Mounib Elchebly, et al.
Pigment Cell & Melanoma Research (2023) Vol. 36, Iss. 3-4, pp. 299-313
Open Access | Times Cited: 2
ROR2, a driver of “phenotype switching” in melanoma?
Pablo Lopez‐Bergami
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Pablo Lopez‐Bergami
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 4
The Role of the Meiotic Component in Reproduction of B-RAF-Mutated Melanoma: A Review and “Brainstorming” Session
Dace Pjanova, Ninel M. Vainshelbaum, Kristīne Salmiņa, et al.
IntechOpen eBooks (2020)
Open Access | Times Cited: 5
Dace Pjanova, Ninel M. Vainshelbaum, Kristīne Salmiņa, et al.
IntechOpen eBooks (2020)
Open Access | Times Cited: 5
Extracellular Vesicles and Cardiovascular Disease: Diagnostic and Therapeutic Perspective
Vivek P. Chavda, Pankti C. Balar, Dixa A. Vaghela, et al.
(2024), pp. 255-287
Closed Access
Vivek P. Chavda, Pankti C. Balar, Dixa A. Vaghela, et al.
(2024), pp. 255-287
Closed Access
CTCFL expression is associated with cerebral vascular abnormalities
Leyla Satı, Bikem Soygur, Ethem Göksu, et al.
Tissue and Cell (2021) Vol. 72, pp. 101528-101528
Closed Access | Times Cited: 3
Leyla Satı, Bikem Soygur, Ethem Göksu, et al.
Tissue and Cell (2021) Vol. 72, pp. 101528-101528
Closed Access | Times Cited: 3
Downregulation of BORIS/CTCFL leads to ROS‐dependent cellular senescence and drug sensitivity in MYCN‐amplified neuroblastoma
Koteswara Rao Garikapati, Venkata Krishna Kanth Makani, Jolly Janette Mendonza, et al.
FEBS Journal (2021) Vol. 289, Iss. 10, pp. 2915-2934
Closed Access | Times Cited: 3
Koteswara Rao Garikapati, Venkata Krishna Kanth Makani, Jolly Janette Mendonza, et al.
FEBS Journal (2021) Vol. 289, Iss. 10, pp. 2915-2934
Closed Access | Times Cited: 3
Tumor–matrix interaction induces phenotypic switching in liver cancer cells
Ray‐Hwang Yuan, Chia‐Lang Hsu, Yu‐Lin Jhuang, et al.
Hepatology International (2022) Vol. 16, Iss. 3, pp. 562-576
Closed Access | Times Cited: 2
Ray‐Hwang Yuan, Chia‐Lang Hsu, Yu‐Lin Jhuang, et al.
Hepatology International (2022) Vol. 16, Iss. 3, pp. 562-576
Closed Access | Times Cited: 2
The function of brother of the regulator of imprinted sites in cancer development
Siqi Zhou, Lian Li, Ming Zhang, et al.
Cancer Gene Therapy (2022) Vol. 30, Iss. 2, pp. 236-244
Closed Access
Siqi Zhou, Lian Li, Ming Zhang, et al.
Cancer Gene Therapy (2022) Vol. 30, Iss. 2, pp. 236-244
Closed Access
Clinical Utility of Noncoding RNAs as Systemic Biomarkers in Animal Models
Siuli Shaw, Sartaj Khurana, Ayushi Mukherjee, et al.
Handbook of Animal Models and its Uses in Cancer Research (2022), pp. 1-17
Closed Access
Siuli Shaw, Sartaj Khurana, Ayushi Mukherjee, et al.
Handbook of Animal Models and its Uses in Cancer Research (2022), pp. 1-17
Closed Access
